Moberg Pharma AB (publ) (MOBS.XC)
Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
As of 02:05PM BST. Market open.
| Previous close | 22.81 |
| Open | 23.20 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 22.81 - 22.81 |
| 52-week range | 20.00 - 34.74 |
| Volume | |
| Avg. volume | 329 |
| Market cap | 676.551M |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.05 |
| Earnings date | 13 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 04 Nov 2019 |
| 1y target est | N/A |
PR NewswireMOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication
Moberg Pharma ABs (OMX: MOB) marker partner in Sweden - Allderma AB, a company which specialises in the sale of over-the-counter (OTC) pharmaceuticals - has now launched sales of MOB-015 under the Terclara® brand. The interest among pharmacies has been significant for Moberg Pharma's medication against nail fungus.
© 2024 Yahoo. All rights reserved.